ProCE Banner Activity

Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Germany (Podcast Pearls)

PDF
Experts from Germany provide their thoughts on recent advances with immune checkpoint therapy for advanced urothelial carcinoma.

Released: May 21, 2021

Expiration: May 20, 2022

No longer available for credit.

Share

Faculty

Georgios Gakis

Georgios Gakis, MD

Professor
Managing Staff Member
Department of Urologoy
Würzburg University
Würzburg, Germany

Supporters

Supported by an educational grant from

Pfizer and EMD Serono

Faculty Disclosure

Primary Author

Georgios Gakis, MD

Professor
Managing Staff Member
Department of Urologoy
Würzburg University
Würzburg, Germany